Education
About Us
Working with TipRanks
Follow Us
Sun Pharmaceutical Industries Limited (IN:SUNPHARMA)
:SUNPHARMA
RESEARCH TOOLSreports
Sonidegib Phosphate Capsules
Carcinoma, Basal Cell (Bcc)
Phase IV
Active Not Recruiting
Sonidegib in Adult Patients With Locally Advanced Basal Cell Carcinoma (laBCC) in China
Mar 12, 2025
―
Tildrakizumab 100 Mg
Moderate To Severe Genital Psoriasis
Phase III
Recruiting
A Study to Evaluate the Efficacy and Safety of Subcutaneous Tildrakizumab in Subjects With Moderate to Severe Genital Psoriasis.
Sep 23, 2024
―
Winlevi (Clascoterone) Cream 1%
Acne Vulgaris
Phase IV
Active Not Recruiting
A Study to Assess Sebaceous Gland Changes and Constituents of Sebum (Skin Oil) Induced by Clascoterone 1% Cream in Acne Patients
May 10, 2024
―
Winlevi (Clascoterone) 1% Cream
Acne Vulgaris
Phase IV
Completed
A Study to Evaluate the Impact of Clascoterone 1% Cream on Skin Barrier Properties in Acne Prone Patients
May 10, 2024
―
Winlevi (Clascoterone) 1% Cream
Acne Vulgaris
Phase IV
Completed
A Study to Evaluate the Reduction in Sebum (Skin Oil) Induced by Clascoterone Cream 1% in Acne Patients
May 10, 2024
―
Winlevi (Clascoterone) 1% Cream
Acne Vulgaris
Phase IV
Completed
A Study Evaluating the Efficacy and Safety of Clascoterone Cream 1% in Skin of Color Patients With Acne
May 10, 2024
―
Winlevi (Clascoterone) 1% & Adapalene 0.3% Gel
Acne Vulgaris
Phase IV
Completed
A Study Assessing the Efficacy of Combined Use of Clascoterone 1% Cream and Adapalene 0.3% for the Treatment of Acne
Mar 11, 2024
―
Winlevi (Clascoterone) 1% & Duac Gel
Acne Vulgaris
Phase IV
Completed
A Study Assessing the Efficacy and Safety of Combined Use of Clascoterone 1% Cream and Duac Gel (Benzoyl Peroxide/Clindamycin) for the Treatment of Acne
Mar 11, 2024
―
Brinzolamide Ophthalmic Suspension, Azopt®
Ocular Hypertension, Primary Open Angle Glaucoma
Phase III
Completed
A Therapeutic Equivalence Study in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension
Aug 19, 2021
―
Tild Sub-Cutaneous (Sc) Injection
Psoriatic Arthritis
Phase III
Recruiting
Long Term Evaluation of Safety and Efficacy of Tildrakizumab in Patients With Psoriatic Arthritis
Jul 29, 2021
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Sun Pharmaceutical Industries Limited (SUNPHARMA) have in its pipeline
SUNPHARMA is currently developing the following drugs: Sonidegib Phosphate Capsules, Tildrakizumab 100 Mg, Winlevi (Clascoterone) Cream 1%. These drug candidates are in various stages of clinical development as the company works toward FDA approval.